Key Information
An 87-year-old male had been under cardiology follow-up since 2013 due to ischaemic heart disease with New York Heart Association (NYHA) functional class II/IV. His medical history included hypercholesterolaemia as a cardiovascular risk factor, osteoarthritis, polymyalgia rheumatica, knee prosthesis, benign prostatic hyperplasia, and a transient ischaemic attack in 2010. He was also under assessment for cognitive decline.
Initial cardiac diagnosis revealed single-vessel coronary artery disease affecting the proximal left anterior descending artery, revascularised with a drug-eluting stent. Left ventricular ejection fraction (LVEF) was preserved with no valvular disease.
Medical therapy included acetylsalicylic acid (100 mg/day), bisoprolol (2.5 mg/day), nitrates, and atorvastatin (20 mg/day). Later, congestive heart failure was attributed to bradycardia, which improved upon beta-blocker withdrawal.